Belanoff Joseph K's Form 4 filing
Corcept Therapeutics Inc (CORT) · filed Apr 2, 2025
- Accession no.
- 0000950170-25-049790
- Filed
- Apr 2, 2025
- Trade date
- Mar 31-Apr 1, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $3.37M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Belanoff Joseph KCIK 0001286199 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Common Stock | SSaleDisposed | −35,102 | $94.72 | −$3,324,861.44 | 2,982,335 | Indirect | |
| Apr 1, 2025 | Common Stock | SSaleDisposed | −350 | $114.71 | −$40,148.5 | 2,981,985 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The power of attorney under which this form was signed is on file with the Commission.